Harvard Study: Half of Adult Americans Eligible for Ozempic-Like Drugs

From Dr. Peter McCullough MD

By Peter A. McCullough, MD, MPH Glucagon-like peptide receptor agonists (GLP-1 RA) are the current financial rainmakers for BIG PHARMA. Shi et al from Harvard reported recently in JAMA Cardiology. Rapidly increasing uptake of semaglutide made it the top-selling drug in the US in 2023, with net sales of $13.8 billion. Quantifying the number of […]

Nov 20th 2024 5:02am EST

Source Link: https://petermcculloughmd.substack.com/p/harvard-study-half-of-adult-americans

Share, promote & comment with Nostr: https://dissentwatch.com/boost/?boost_post_id=878237 

 I have an uneasy feeling that Ozempic will be the next thalidomide scandal, I hope it's just that, an uneasy feeling.

nostr:nevent1qqs2umy5u04gu4lw6qpw3jvgu80gyfxdqmuwg4qas34agcgvk5kkuugpz3mhxue69uhhyetvv9ujuerpd46hxtnfdupzpkvpty0qafs48wrg0v4w6ec2klvmdsadqx9rvzegyzeu7rmupt3hqvzqqqqqqy25llu2